Endo Targets Actavis Over Generic Versions Of Opana
Endo Pharmaceuticals Inc. on Tuesday launched patent infringement and false advertising suits against Actavis Inc. in New York and New Jersey federal courts, respectively, in yet another effort to keep copycat...To view the full article, register now.
Already a subscriber? Click here to view full article